The dirty dozen: 12 Myths that undermine tobacco control

American Journal of Public Health

Volumn 95, Issue 9, 2005, Pages 1500-1505

  Frieden, Thomas R ^a   Blakeman, Drew E ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; CIGARETTE SMOKING; COMMERCIAL PHENOMENA; HEALTH EDUCATION; HEALTH HAZARD; HUMAN; REVIEW; SMOKING CESSATION; TOBACCO INDUSTRY; UNITED STATES;

ADOLESCENT; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; MARKETING; MYTHOLOGY; PUBLIC HEALTH; SMOKING CESSATION; TOBACCO INDUSTRY; TOBACCO USE DISORDER;

EID: 24144473389     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2005.063073     Document Type: Review

References (114)

1. Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR Morb Mortal Wkly Rep. 2005;54:625-62 8.
2. Cigarette smoking-attributable morbidity-United States, 2000. MMWR Morb Mortal Wkly Rep. 2003;52:842-844.
3. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362: 847-852.
4. Mackay J, Eriksen M. The Tobacco Atlas. Geneva, Switzerland: World Health Organization; 2002.
5. Cigarette smoking among adults-United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;53:427-431.
6. Cliarlton A. Tobacco or health 1602: an Elizabethan doctor speaks. Health Edite Res. 2005;20:101-111.
7. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: a preliminary report. BMJ. 1954;ii: 1451-1455.
8. Federal Trade Commission Cigarette Report for 2002. Washington, DC: Federal Trade Commission: 2004.
9. Basil MD, Basil DZ, Schooler C. Cigarette advertising to counter New Year's resolutions. J Health Commun. 2000;5:161-174.
10. Shafey O, Fernandez, E, Thun M, et al. Cigarette advertising and female smoking prevalence in Spain, 1982-1997: case studies in International Tobacco Surveillance. Cancer. 2004;100: 1744-1749.
11. O'Keefe AM, Pollay RW. Deadly targeting of women in promoting cigarettes. J Am Med Womens Assoc. 1996; 51:67-69.
12. Ling PM, Glantz SA. Why and how the tobacco industry sells cigarettes to young adults: evidence from industry documents. Am J Public Health. 2002; 92:908-916.
13. Katz SK, Lavack AM. Tobacco-related bar promotions: insights from tobacco industry documents. Tob Control. 2002:11(suppl 1)1:192-101.
14. Gardiner PS. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res. 2004;6(suppl I):S55-S65.
15. Stevens P, Carlson LM, Hinman JM. An analysis of tobacco industry marketing to lesbian, gay, bisexual, and transgender (LGBT) populations: strategies for mainstream tobacco control and prevention. Health Promot Pract. 2004; 5(suppl 1):129-134.
16. Pierce JP, Gilpin EA. A historical analysis of tobacco marketing and the uptake of smoking by youth in the United States: 1890-1977. Health Psychol. 1995;14:500-508.
17. Pierce JP, Gilpin E, Burns DM. et al. Does tobacco advertising target young people to start smoking? Evidence from California. JAMA. 1991; 266:3154-3158.
18. Evans N, Farkas A, Gilpin E, et al. Influence of tobacco marketing and exposure to smokers on adolescent susceptibility to smoking. J Natl Cancer Inst. 1995;87:1538-1545.
19. While D, Kelly S, Huang W, et al. Cigarette advertising and onset of smoking in children: questionnaire survey. BMJ. 1996;313:398-399.
20. Pierce JP, Choi WS, Cilpin EA, et al. Tobacco industry promotion of cigarettes and adolescent smoking. [Erratum published in JAMA. 1998;280:422]. JAMA. 1998;279:511-515.
21. MacFadyen L, Hastings G, MacKintosh AM. Cross-sectional study of young people's awareness of and involvement with tobacco marketing. BMJ. 2001;322:513-517.
22. Donovan RJ, Jancey J, Jones S. Tobacco point-of-sale advertising increases positive brand user imageiy. Tob Control. 2002;11:191-194.
23. Reuter B. Table: competitive analysis 1st draft, organization 1st draft, production to follow. 1992 (est.). Bates: 202118664-202118680. Available at: http://tobaccodocuments.org/pm/ 2021118664-8680.html. Accessed April 5, 2005.
24. Chen J, Millar WJ. Age of smoking initiation: implications for quitting. Health Rep. 1998;9:39-46.
25. Preventing tobacco use among young people: a report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services; 1994.
26. Cigarette smoking among adults-United States, 2000. MMWR Morb Mortal Hilly Rep. 2002;51:642-645.
27. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Bethesda. Md: National Cancer Institute; 2001.
28. Armitage AK, Dixon M, Frost BE, et al. The effect of tobacco blend additives on the retention of nicotine and solanesol in the human respiratory tract and on subsequent plasma nicotine concentrations during cigarette smoking. Chem Res Toxicol. 2004;17:537-544.
29. Roth LK, Taylor HS. Risks of smoking to reproductive health: assessment of women's knowledge. Am J Obstet Gynecol. 2001;184:934-939.
30. Kirkland SA, MacLean DR, Languie DB, et al. Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992. CMAJ. 1999;161(suppl 8):S10-S16.
31. Yang G, Ma J, Chen A, et al. Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control 2001;10:170-174.
32. Shelley D, Fahs M, Scheinmann R, Swain S, Qu J, Burton D. Acculturation and tobacco use among Chinese Americans. Am J Public Health. 2004;94: 300-307.
33. Frank E, Denniston M, Pederson L. Declines in smokers' understanding of tobacco's hazards between 1986 and 1998: a report from north Georgia. South Med J. 2002;95:675-680.
34. The health consequences of smoking: a report of the Surgeon General. Washington, DC: US Dept of Health and Human Services; 2004.
35. Law MR, Morris JK, Watt HC, WaId NJ. The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer. 1997;75: 1690-1693.
36. Prescott E, Scharling H, Osler M, et al. Importance of light smoking and inhalation habits on risk of myocardial infarction and all-cause mortality. A 22-year follow-up of 12 149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health. 2002;56:702-706.
37. Pechacek TF, Babb S. How acute and reversible are the cardiovascular risks of secondhand smoke? BMJ. 2004;328:980-983.
38. Ventura SJ, Hamilton BE, Mathews TJ, et al. Trends and variations in smoking during pregnancy and low birth-weight: evidence from the birth certificate, 1990-2000. Pediatrics. 2003;111: 1176-1180.
39. Yang W, Jcnnison BL, Omaye ST. Cardiovascular disease hospitalisation and ambient levels of carbon monoxide. J Toxicol Environ Health A. 1998;55: 185-196.
40. Benowitz NL. The role of nicotine in smoking-relatcd cardiovascular disease. Prev Med. 1997;26:412-417.
41. Cohen JB. Smokers' knowledge and understanding of advertised tar numbers: health policy implications. Am J Public Health. 1996;86:18-24.
42. Gilpin EA, Emery S, White MM, et al. Does tobacco industry marketing of "light" cigarettes give smokers a rationale for postponing quitting? Nicotine Tob Res. 2002;4(suppl 2):S147-S155.
43. Federal Cigarette Labeling and Advertising Act of 1965. Pub. L. No. 89-92, 15 U.S.C. 1331 et seq. (July 27, 1965, as amended by Pub. L. No. 91-222, 84 Stat. 87, Apr. 1, 1970 and Pub. L. No. 98-474, 98 Stat. 2204, Oct. 12, 1984).
44. Information for smokers. Richmond, Va.: Philip Morris USA; 2004. Available at: http://www.philipmorris-usa.com/downloads/healthjssues/ low_tar_cigarettes/onscrt.pdf. Accessed April 5, 2005.
45. WHO framework convention on tobacco control. Geneva: World Health Organization. May 1, 2003. Available at: http://www.who.int/tobacco/fctc/ text/en/fctc_en.pdf. Accessed April 5, 2005.
46. Kozlowski LT, Goldberg ME, Yost BA, et al. Smokers' misperccptions of light and ultra-light cigarettes may keep them smoking. Am J Prea Med. 1998; 15:9-16.
47. Ling PM, Glantz SA. Tobacco industry research on smoking cessation. Recapturing young adults and other recent quitters. J Gen Intern Med. 2004; 19(5 Pt 1):419-426.
48. Pollay RW, Dewhirst T. The dark side of marketing seemingly "light" cigarettes: successful images and failed fact. Tob Control. 2002;11(suppl 1):I18-I31.
49. FTC Consumer Alert. Up in Smoke: The Truth About Tar and Nicotine Ratings. Washington, DC: Federal Trade Commission; 2000.
50. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health. 1997;50:307-364.
51. Darnell A. Memorandum re: Philip Morris documents. Sept. 1, 1987. Available at: http://tobaccodocuments.org/ landman/28340.html. Accessed April 5, 2005.
52. The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. Rockville. Md: US Dept of Health and Human Services; 1988.
53. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994;309:901-911.
54. Tobacco. 19830000;19870205. Bates: 504231648-504231658. Available at: http://tobaccodocuments.org/ rjr/504231648-1658_D1.html. Accessed April 5, 2005.
55. Stolerman IP, Jarvis MJ. The scientific case that nicotine is addictive. Psychopharmacology (Berl). 1995;117:2-10.
56. The Health Benefits of Smoking Cessation: A Report of the Surgeon General Rockville, Md: US Dept of Health and Human Services; 1990.
57. Cigarette smoking among adults-United States, 1995. MMWR Morb Mortal Wkly Rep. 1997;46:1217-1220.
58. Zhu S, Melcer T, Sun J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med. 2000;18:305-311.
59. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville Md: US Dept of Health and Human Services, Public Health Service; 2000.
60. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library. Issue 2. Chichester, UK: John Wiley & Sons, Ltd; 2004.
61. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337: 1195-1202.
62. Swan GE, McAfee T, Curry SJ, et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med. 2003;163: 2337-2344.
63. Croghan GA, Sloan JA, Croghan IT, et al. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob Res. 2003;5:181-187.
64. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med. 2000;160:3128-3134.
65. Jamerson BD, Nides M, Jorenby DE, et ai. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clin Ther. 2001;23:744-752.
66. Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002;51:300-303.
67. Martel L, Belanger A, Berthelot JM. Smoking and disability-free life in Canada. In: Report on the Demographic Situation in Canada 2000: Current Demographic Analysis. Ottawa, Ont: Statistics Canada; 2001.
68. Nusselder WJ, Looman CW, Marang-van de Mheen PJ, et al. Smoking and the compression of morbidity. J Epidemiol Community Health. 2000; 54:566-574.
69. Arday DR, Milton MH, Husten CG, et al. Smoking and Functional status among Medicare managed care enrollees. Am J Prev Med. 2003;24: 234-241.
70. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004;328:1519-1527.
71. Janson C. The effect of passive smoking on respiratory health in children and adults. Int J Tuberc Lung Dis. 2004;8:510-516.
72. Iribarren C, Darbinian J, Klatsky AL, Friedman GD. Cohort study of exposure to environmental tobacco smoke and risk of first ischemic stroke and transient ischemic attack. Neuroepidemiology. 2004;23:38-44.
73. Pitsavos C, Panagiotakos DB, Chrysohoou C, et al. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control. 2002;11:220-225.
74. Otsuka R, Watanabe H, Hirata K, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA. 2001;286: 436-441.
75. Woodward A, Laugesen M. How many deaths are caused by secondhand cigarette smoke? Tob Control. 2001;10:383-388.
76. Hill S, Blakely T, Kawachi I, Woodward A. Mortality among "never smokers" living with smokers: two cohort studies, 1981-4 and 1996-9. BMJ. 2004;328:988-989.
77. Law MR, Hackshaw AK. Environmental tobacco smoke. Br Med Bull. 1996;52:22-34.
78. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315: 973-980.
79. Coultas DB. Passive smoking and risk of adult asthma and COPD: an update. Thorax. 1998;53:381-387.
80. Anderson HR, Cook DG. Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax. 1997;52: 1003-1009.
81. Jha P, Chaloupka FJ. Curbing the Epidemic: Governments and the Economics of Tobacco Control Washington, DC: The World Bank; 1999.
82. Warner KE, Fulton GA, Nicolas P, Grimes DR. Employment implications of declining tobacco product sales for the regional economies of the United States. JAMA. 1996;275:1241-1246.
83. Capehart T. The changing tobacco user's dollar. Washington, DC: US Dept of Agriculture, Economic Research Service; 2004. Outlook Report No. TBS257-01.
84. Harris JR, Schauffler HH, Milstein A, Powers P, Hopkins DP. Expanding health insurance coverage for smoking cessation treatments: experience of the Pacific Business Group on Health. Am J Health Promot. 2001;15:350-356.
85. Halpern MT, Shikiar R, Rentz AM, Khan ZM. Impact of smoking status on workplace absenteeism and productivity. Tob Control. 2001;10:233-238.
86. Warner KE. Cost-effectiveness of smoking-cessation therapies. Interpretation of the evidence and implications for coverage. Pharmacoeconomics. 1997; 11:538-549.
87. Tobacco use, access, and exposure to tobacco in media among middle and high school students-United States, 2004. MMWA Morb Mortal Wkly Rep. 2005;54:297-301.
88. Jamrozik K. Population strategies to prevent smoking. BMJ. 2004;328: 759-762.
89. Master settlement agreement (as amended). Available at: http:// www.naag.org/issues/tobacco/indcx. php?sdpid=919. Accessed April 5, 2005.
90. Lombardi F, Saltonstall O. Firms stoked to fight smoke ban. New York Daily News. September 19, 2002:14.
91. Tobacco Industry Strategies to Undermine Tobacco Control Activities at the World Health Organization. Geneva, Switzerland: World Health Organization; July 2000.
92. Glantz SA. The truth about big tobacco in its own words. BMJ. 2000; 321:313-314.
93. Francey N, Chapman S. "Operation Berkshire": the international tobacco companies' conspiracy. BMJ. 2000;321: 371-374.
94. Kasindorf M. Tobacco execs launch attack on anti-smoking ads. USA Today. June 8, 2003:A4.
95. Hirschhorn N. Corporate social responsibility and the tobacco industry: hope or hype? Tob Control. 2004;13: 447-453.
96. Chung PJ, Garfield CF, Rathouz PJ, et al. Youth targeting by tobacco manufacturers since the Master Settlement Agreement. The first study to document violations of the youth-targeting ban in magazine ads by the three top US tobacco companies. Health Aff (Millwood). 2002;21:254-263.
97. King C III, Siegel M. The Master Settlement Agreement with the tobacco industry and cigarette advertising in magazines. N Engl J Med. 2001;345: 504-511.
98. Sargent JD, Dalton M, Beach M. Exposure to cigarette promotions and smoking uptake in adolescents: evidence of a dose-response relation. Tob Control. 2000;9:163-168.
99. Campaign for Tobacco-Free Kids. New poll shows kids still bombarded with tobacco advertising [press release]. Apr. 3, 2002. Available at: http://tobaccofreekids.org/Script/ DisplayPressReleasc.php3?Display=472. Accessed April 5, 2005.
100. Pollay RW, Siddarth S, Siegel M, et al. The last straw? Cigarette advertising and realized market shares among youths and adults, 1979-1993. J Marketing. 1996;60:1-16.
101. Dalton MA, Sargent JD, Beach ML, et al. Effect of viewing smoking in movies on adolescent smoking initiation: a cohort study. Lancet. 2003;362: 281-285.
102. Glantz SA, Kacirk KW, McCulloch C. Back to the future: smoking in movies in 2002 compared with 1950 levels. Am J Public Health. 2004;94: 261-263.
103. Sargent JD, Tickle JJ, Beach ML, Dalton MA, Ahrens MB, Heatherton TF. Brand appearances in contemporary cinema films and contribution to global marketing of cigarettes. Lancet. 2001; 357:29-32.
104. Tickle JJ, Sargent JD, Dalton MA. Beach ML, Heatherton TK Favourite movie stars, their tobacco use in contemporary movies, and its association with adolescent smoking. Tob Control. 2001;10:16-22.
105. DuRant RH, Rome LS, Rich M, et al. Tobacco and alcohol use behaviors portrayed in music videos: a content analysis. [Published erratum in Am J Public Health. 1997;87:1514.] Am J Public Health. 1997;87:1131-1135.
106. Wakefield M, Flay B, Nichter M, et al. Role of the media in influencing trajectories of youth smoking. Addiction. 2003;98(suppl 1):79-103.
107. Pierce JP, Distefan JM, Jackson C, et al. Does tobacco marketing undermine the influence of recommended parenting in discouraging adolescents from smoking? Am J Prev Med. 2002; 23:73-81.
108. Family MC, Hcalton CG, Davis KC, Messeri P, Hersey JC, Haviland ML. Getting to the truth: evaluating national tobacco countermarketing campaigns [Published erratum in Am J Public Health. 2003;93:703]. Am J Public Health. 2002;92:901-907
109. Hu T, Sung HY, Keeler TF. Reducing cigarette consumption in California: tobacco taxes vs an anti-smoking media campaign. Am J Public Health. 1995;85: 1218-1222.
110. Pierce JP, Macaskill P, Hill D. Long-term effectiveness of mass media-led anti-smoking campaigns in Australia. Am J Public Health. 1990;80:565-569.
111. Macaskill P, Pierce JP, Simpson JM, Lyle DM. Mass media-led anti-smoking campaign can remove the education gap in quitting behavior. Am J Public Health. 1992;82:96-98.
112. Flynn BS, Worden JK, Seeker-Walker RH, Badger GJ, Geller BM, Costanza MC. Prevention of cigarette smoking through mass media intervention and school programs. Am J Public Health. 1992;82:827-834.
113. Perry CL, Kelder SH, Murray DM, Klepp KI. Communitywide smoking prevention: long-term outcomes of the Minnesota Heart Health Program and the Class of 1989 Study. Am J Public Health. 1992;82:1210-1216.
114. Frieden TR, Mostashari F, Kerker BD, Miller N, Hajat A, Frankel M. Adult tobacco use levels after intensive tobacco control measures: New York City, 2002-2003. Am J Public Health. 2005; 95:1016-1023.